Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Temaer i nordisk bibliotekshistorie
View through CrossRef
Det kan allerede kaldes en tradition, at IFLAs Round Table on Library History, enten i forbindelse med IFLA konferencer eller uafhængigt heraf, afholder særlige møder med både internationale temaer og regionalt afgrænsede bibliotekshistoriske emner. Nævnes kan således det internationale seminar Libraries at times of cultural change, som fandt sted i august 1987 i Brighton, i snævert samarbejde med og under ledelse af den britiske Library Association's Library History Group, det internationale seminar om Øst- og Mellemeuropas bibliotekshistorie, som nogle måneder før afholdtes i Wroclaw efter indbydelse fra polske kolleger, samt det symposium om Library history research in the international context, som i april 1988 fandt sted i Wolfenbuttel i samarbejde med Wolfenbiitteler Arbeitskreis fiir Bibliotheksgeschichte.
Title: Temaer i nordisk bibliotekshistorie
Description:
Det kan allerede kaldes en tradition, at IFLAs Round Table on Library History, enten i forbindelse med IFLA konferencer eller uafhængigt heraf, afholder særlige møder med både internationale temaer og regionalt afgrænsede bibliotekshistoriske emner.
Nævnes kan således det internationale seminar Libraries at times of cultural change, som fandt sted i august 1987 i Brighton, i snævert samarbejde med og under ledelse af den britiske Library Association's Library History Group, det internationale seminar om Øst- og Mellemeuropas bibliotekshistorie, som nogle måneder før afholdtes i Wroclaw efter indbydelse fra polske kolleger, samt det symposium om Library history research in the international context, som i april 1988 fandt sted i Wolfenbuttel i samarbejde med Wolfenbiitteler Arbeitskreis fiir Bibliotheksgeschichte.
Related Results
12481 Evaluating The Device Handling And Preference Assessment Questionnaire For Growth Hormone Deficiency: Results From Content Validation Interviews
12481 Evaluating The Device Handling And Preference Assessment Questionnaire For Growth Hormone Deficiency: Results From Content Validation Interviews
Abstract
Disclosure: J. Neergaard: Employee; Self; Novo Nordisk. S. Akhtar: Employee; Self; Novo Nordisk. Stock Owner; Self; Novo Nordisk. B. Berg: Employee; Self; N...
Insulin Degludec Has Lower Hypoglycemia Risk than Insulin Glargine U100 in Older People with Type 2 Diabetes (T2D)
Insulin Degludec Has Lower Hypoglycemia Risk than Insulin Glargine U100 in Older People with Type 2 Diabetes (T2D)
Vulnerability to hypoglycemia increases with age. To further assess the safety of insulin in older patients, the risk of hypoglycemia was investigated post-hoc in the SWITCH 2 trea...
1651-P: Elevated FGF21 Levels after Total Pancreatectomy and in Response to Single-Dose Glucagon Receptor Antagonism in Humans
1651-P: Elevated FGF21 Levels after Total Pancreatectomy and in Response to Single-Dose Glucagon Receptor Antagonism in Humans
Fibroblast growth factor 21 (FGF21) is a liver-secreted peptide hormone reportedly improving metabolic homeostasis, partly via reduced hunger for sugar, fat, protein and alcohol. E...
Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)
Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)
Abstract
Introduction
The short half-life of standard factor VIII (FVIII) products means that frequent injections (3 to 4 times/week) are needed for e...
Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Hemophilia a or B with Inhibitors: Results from explorer4, a Phase 2, Randomized, Open-Label, Controlled Trial
Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Hemophilia a or B with Inhibitors: Results from explorer4, a Phase 2, Randomized, Open-Label, Controlled Trial
Introduction Concizumab is an anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody in clinical development for the subcutaneous prophylactic treatment of hemophilia pati...
105-LB: Glucose Variability with Second-Generation Basal Insulin Analogs Glargine 300 U/mL and Degludec 100 U/mL, Evaluated by CGM in People with T1D—The InRange Randomized Controlled Trial
105-LB: Glucose Variability with Second-Generation Basal Insulin Analogs Glargine 300 U/mL and Degludec 100 U/mL, Evaluated by CGM in People with T1D—The InRange Randomized Controlled Trial
Background: InRange has previously demonstrated that insulin glargine 300 U/mL (Gla-300) is non-inferior to insulin degludec 100 U/mL (IDeg-100) in terms of time in glucose range 7...
62-OR: Evidence of Gut-Derived Glucagon in Man
62-OR: Evidence of Gut-Derived Glucagon in Man
We have previously shown that totally pancreatectomized patients (PX) and patients with type 2 diabetes (T2D) exhibit hypersecretion of glucagon in response to oral glucose stimula...
Hypoglycemia with Mealtime Fast-Acting Insulin Aspart vs. Insulin Aspart Across Two Large Type 1 Diabetes Trials
Hypoglycemia with Mealtime Fast-Acting Insulin Aspart vs. Insulin Aspart Across Two Large Type 1 Diabetes Trials
Hypoglycemia is a ubiquitous challenge with insulin treatment in type 1 diabetes (T1D), with nocturnal episodes of particular concern. Severe (as defined by the ADA) or blood gluco...